References
- Chow LC, Wright KW, Sola A. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics. 2003;111(2):339–345. doi:https://doi.org/10.1542/peds.111.2.339.
- Bullard SR, Donahue SP, Feman SS, Sinatra RB, Walsh WF. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS. 1999;3(1):46–52. doi:https://doi.org/10.1016/S1091-8531(99)70094-7.
- Hariharan L, Gilbert CE, Quinn GE, et al. Reducing blindness from retinopathy of prematurity (ROP) in Argentina through collaboration, advocacy and policy implementation. Health Policy Plan. 2018;33:654–665. doi:https://doi.org/10.1093/heapol/czy004.
- Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS. 1999;3:26–32. doi:https://doi.org/10.1016/S1091-8531(99)70091-1.
- Sommer A, Hussaini G, Tarwotjo I, Susanto D. Increased mortality in children with mild vitamin a deficiency. Lancet. 1983;322:585–588. doi:https://doi.org/10.1016/S0140-6736(83)90677-3.
- Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350:12–14. doi:https://doi.org/10.1016/S0140-6736(97)01107-0.
- Gilbert C, Foster A. Childhood blindness in the context of VISION 2020: the right to sight. Bull World Health Organ. 2001;79:227–232. doi:https://doi.org/10.1590/S0042-96862001000300011.
- Gilbert C. Changing challenges in the control of blindness in children. Eye. 2007;21:1338–1343. doi:https://doi.org/10.1038/sj.eye.6702841.
- Chawanpaiboon S, Vogel JP, Moller A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7:e37–e46. doi:https://doi.org/10.1016/S2214-109X(18)30451-0.
- Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(S1):35–49. doi:https://doi.org/10.1038/pr.2013.205.
- Lloyd T, Isenberg S, Lambert SR. Current management of retinopathy of prematurity in sub-Saharan Africa. J AAPOS. 2020;24(3):151.e1-151.e6. Published online June 4. doi:https://doi.org/10.1016/j.jaapos.2020.03.002.
- Shah PK, Narendran V, Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child - Fetal Neonatal Ed. 2012;97(5):F371–F375. doi:https://doi.org/10.1136/fetalneonatal-2011-301121.
- Gezmu AM, Shifa JZ, Quinn GE, et al. Incidence of retinopathy of prematurity in Botswana: a prospective observational study. Clin Ophthalmol. 2020;14:2417–2425. doi:https://doi.org/10.2147/OPTH.S265664.
- Kabesha TB, Kabesha D, Rehema G, et al. [Result of intravitreal injection of Bevacizumab (Avastin) in the treatment of retinopathy of prematurity (About 11 cases followed up at Bukavu from 01.01 2014 to 06.30 2016)]. Lubumbashi Med J Fac Med. December 2018; Published online. doi:https://doi.org/10.13140/RG.2.2.18193.28004.
- Gyawali R, Bhayal BK, Adhikary R, Shrestha A, Sah RP. Retrospective data on causes of childhood vision impairment in Eritrea. BMC Ophthalmol. 2017;17:1–8. doi:https://doi.org/10.1186/s12886-017-0609-x.
- Melesse MA. Retinopathy of prematurity - an emerging cause of childhood blindness in Ethiopia. Ethiop Med J. 2020;58:167–172.
- Almeida AA Causes of blindness and severe visual impairment among students attending school for the blind in Beira, Mozambique [Thesis]. Nairobi, KY; 2016.
- Olowoyeye AO, Musa KO, Aribaba OT, Onakoya AO, Akinsola FB. Pattern of childhood visual impairment and blindness among students in schools for the visually impaired in Lagos State: an update. Niger Postgrad Med J. 2018;25:105–111. doi:https://doi.org/10.4103/npmj.npmj_27_18.
- Jacoby MR, Toit LD. Screening for retinopathy of prematurity in a provincial hospital in Port Elizabeth, South Africa. S Afr Med J. 2016;106(6):598–601. doi:https://doi.org/10.7196/SAMJ.2016.v106i6.10663.
- Botha TC Retinopathy of prematurity: a case series of treated infants [Thesis]. Bloemfontein, SA: University of the Free State; 2017
- Dadoo Z, Ballot DE. An evaluation of the screening for retinopathy of prematurity in very-low-birth-weight babies at a tertiary hospital in Johannesburg, South Africa. South Afr J Child Health. 2016;10(1):79–82. doi:https://doi.org/10.7196/SAJCH.2016.v10i1.1099.
- Kana H, Mayet I, Soma D, Alli HD, Biddulph S. The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: experience from a tertiary hospital. S Afr Med J. 2017;107(3):215–218. doi:https://doi.org/10.7196/SAMJ.2017.v107i3.11080.
- Saleem M, Abdalla N. Screening of retinopathy of prematurity in Khartoum city, Sudan, 2011-2012. Merit Res J Microbiol Biol Sci. 2014;2:25–30.
- Du Bruyn A, Visser L. Eight years of treatable retinopathy of prematurity in KwaZulu-Natal : are we winning the battle? South Afr Ophthalmol J. 2017;12:8–10.
- The World Bank. Mortality rate, neonatal (per 1,000 live births). data.worldbank.org. Published 2018. Accessed August 15, 2020. https://data.worldbank.org/indicator/SH.DYN.NMRT?end=2018&name_desc=true&start=2016
- Gilbert C, Malik ANJ, Nahar N, et al. Epidemiology of ROP update – Africa is the new frontier. Semin Perinatol. 2019;43:317–322. doi:https://doi.org/10.1053/j.semperi.2019.05.002.
- Hug L, Alexander M, You D, Alkema L. National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis. Lancet Glob Health. 2019;7:e710–e720. doi:https://doi.org/10.1016/S2214-109X(19)30163-9.
- Sitati SM, Ojuma SM, Alba C de. Retinopathy of prematurity: prevalence and risk factors among infants in rural Kenya. J Ophthalmol East Cent South Afr. 2018;22:63–67.
- Wang D, Duke R, Chan RP, Campbell JP. Retinopathy of prematurity in Africa: a systematic review. Ophthalmic Epidemiol. 2019;26:223–230. doi:https://doi.org/10.1080/09286586.2019.1585885.
- Mutangana F, Muhizi C, Mudereva G, et al. Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services. Eye. 2019;34(5):847–856.doi:https://doi.org/10.1038/s41433-019-0529-5.
- Nti AA, Essuman VA, Enweronu-Laryea C, Ofori-Darko A, Quinn GE. Babies at risk for retinopathy of prematurity in Ghana. J AAPOS. 2015;19:e55. doi:https://doi.org/10.1016/j.jaapos.2015.07.174.
- Braimah IZ, Enweronu-Laryea C, Sackey AH, et al. Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: a baseline prospective study. BMJ Open. 2020;10:e035341. doi:https://doi.org/10.1136/bmjopen-2019-035341.
- Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618–637. doi:https://doi.org/10.1016/j.survophthal.2018.04.002.
- Kulkarni S, Gilbert C, Zuurmond M, Agashe S, Deshpande M. Blinding retinopathy of prematurity in Western India: characteristics of children, reasons for late presentation and impact on families. Indian Pediatr. 2018;55:665–670. doi:https://doi.org/10.1007/s13312-018-1355-8.
- Visser L, Singh R, Young M, Lewis H, McKerrow N. Guideline for the prevention, screening and treatment of retinopathy of prematurity (ROP). S Afr Med J. 2013;103:116–125. doi:https://doi.org/10.7196/SAMJ.6305.
- Sitati S, Mwangi N, Njambi L, et al. National guidelines for screening and management of retinopathy of prematurity in Kenya: an overview of the recommendations. JOECSA. July 2019; 23:3–5. Published online.
- Fierson WM. Ophthalmology AAOPS on, Ophthalmology AAO, Strabismus AA for POA, Orthoptists AA of C. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142:e20183061. doi:https://doi.org/10.1542/peds.2018-3061.
- Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020;24(3):149.e1-149.e5. Published online May 24. doi:https://doi.org/10.1016/j.jaapos.2020.03.003.
- VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American academy of ophthalmology. Ophthalmology. 2017;124:619–633. doi:https://doi.org/10.1016/j.ophtha.2016.12.025.
- Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017;102:853–857. doi:https://doi.org/10.1136/archdischild-2016-310532.
- Rahi JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet. 2003;362:1359–1365. doi:https://doi.org/10.1016/S0140-6736(03)14631-4.
- Chong C, McGhee CNJ, Dai SH. Causes of childhood low vision and blindness in New Zealand. Clin Exp Ophthalmol. 2019;47(2):165–170. doi:https://doi.org/10.1111/ceo.13443.